Your Gene Therapy Partner From Discovery To Commercialization
The MilliporeSigma organization is dedicated to supporting your cell and gene therapy from early phase through product release. Not only does our BioReliance® Services organization have over 25 years of experience in manufacturing viral vectors, we can also leverage the innovative products and services within the wider organization to support your therapy.
This video will highlight three ways you can partner with us to optimize the productivity of your cell line. For those beyond the discovery phase, this video will highlight how our Process Development group helps ensure success from clinic to commercialization.